QT prolongation

Last edited 03/2023 and last reviewed 03/2023

Prolongation of the QT interval can lead to a life threatening ventricular arrhythmia known as torsades de pointes which can result in sudden cardiac death

Normal QT interval (1):

  • QT interval varies with heart rate
  • females have a longer QT interval than males
  • definitions vary in the literature but as a guide, normal QTc intervals are <450 milliseconds (ms) for men and <460 ms for women
  • a QTc between these values and 500 ms is considered prolonged
    • a QTc >500 ms is considered clinically significant and is likely to confer an increased risk of arrhythmia- immediate secondary care review is indicated

A prolonged QT interval is associated with possible development of ventricular arrhythmia, syncope and sudden death (2):

  • QT interval on the ECG, measured from the beginning of the QRS complex to the end of the T wave
  • QT interval represents the duration of activation and recovery of the ventricular myocardium
    • if there is a prolonged recovery from electrical excitation contributes to increased likelihood of dispersion of refractoriness ( i.e. when some part of myocardium might be refractory to subsequent depolarization)
      • if this occurs then the wave of excitation may pursue a distinctive pathway around a focal point in myocardium (circus reentrant rhythm)
        • resulting in ventricular arrhythmia, hemodynamically ineffective contraction of the ventricles, syncope, and, possibly, sudden death

Magnitude of drug induced changes in QT interval (1):

  • the degree by which a drug changes the QTc interval from baseline is also important
    • an increase in baseline QTc of around 5 ms or less is not considered significant and this is the threshold for regulatory concern
    • for drugs that increase the QTc interval by less than 20 ms the data are inconclusive with regard to arrhythmic risk
      • a change in baseline QTc of >20 ms should raise concern and a change of >60 ms should raise greater concern regarding the potential for arrhythmias
      • evidence from congenital long QT syndrome indicates that for every 10 ms increase in QTc there is a 5-7% increase in risk of torsades de pointes
    • drug-induced QT prolongation is often dose related and risk of torsades de pointes is increased with intravenous administration (particularly if given rapidly).

Click here for an example ECG and further information regarding prolonged QT interval

  • if QTc >500 ms is considered clinically significant and is likely to confer an increased risk of arrhythmia- immediate cardiology/specialist/secondary care advice/review is indicated
  • if QTc is prolonged but less than 500ms, then consider stopping medication associated with increased QT if clinically possible and seek urgent cardiology advice

Consider the following predisposing risk factors into account before starting a medicine known to cause a long QT interval (3):

  • female gender
  • age over 65 years
  • structural or conduction related cardiac disease (e.g. heart failure, ventricular hypertrophy, myocardial infarction, recent conversion from atrial fibrillation)
  • impaired liver or kidney function
  • thyroid disease (more common with hypothyroidism and usually normalises with treatment)
  • congenital long QT syndrome
  • family history of sudden death
  • genetic variations affecting the medicine’s therapeutic or adverse effects
  • diabetes

Following modifiable risk factors can increase the risk of a long QT interval (3)

  • electrolyte disturbances (low potassium, calcium or magnesium levels)
  • bradycardia
  • medicine factors

Reference:

Related pages:

aetiology and risk factors

complications

QT interval

ranolazine

precautions for using drugs which prolong QT interval